Log in
OTCMKTS:EMIS

Emisphere Technologies Stock Forecast, Price & News

$7.80
+0.02 (+0.26 %)
(As of 12/4/2020 12:00 AM ET)
Add
Compare
Today's Range
$7.78
Now: $7.80▼
$7.82
50-Day Range
$6.55
MA: $7.47▼
$7.89
52-Week Range
$4.06
Now: $7.80▼
$9.16
Volume225,148 shs
Average Volume74,414 shs
Market Capitalization$672.22 million
P/E RatioN/A
Dividend YieldN/A
Beta1.54
Emisphere Technologies, Inc. operates as a commercial stage pharmaceutical and drug delivery company in the United States. The company offers oral Eligen B12 Rx, an oral formulation prescription medical food for use by B12 deficient individuals. It is also developing GLP-1, which is in Phase III clinical trial for the treatment of type 2 diabetes and related conditions. The company's preclinical programs focus on the development of oral formulations for the treatment of diabetes; and products in the areas of cardiovascular, appetite suppression, and pain, as well as in the development and expansion of nutritional supplement products. It has license agreements with Novo Nordisk A/S to develop and commercialize oral formulations of GLP-1 receptor agonists in combination with Emisphere carriers, as well as to develop and commercialize oral formulations of Novo Nordisk's insulin using the company's Eligen Technology. The company was formerly known as Clinical Technologies Associates, Inc. and changed its name to Emisphere Technologies, Inc. in 1991. Emisphere Technologies, Inc. was founded in 1986 and is based in Roseland, New Jersey.

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.85 out of 5 stars


Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:EMIS
Previous Symbol
CUSIPN/A
CIK805326
Webwww.emisphere.com
Phone973-532-8000
Employees6

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding Shares86,182,000
Market Cap$672.22 million
Next Earnings DateN/A
OptionableNot Optionable
$7.80
+0.02 (+0.26 %)
(As of 12/4/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive EMIS News and Ratings via Email

Sign-up to receive the latest news and ratings for EMIS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Emisphere Technologies (OTCMKTS:EMIS) Frequently Asked Questions

How has Emisphere Technologies' stock price been impacted by COVID-19 (Coronavirus)?

Emisphere Technologies' stock was trading at $6.45 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, EMIS shares have increased by 20.9% and is now trading at $7.80.
View which stocks have been most impacted by COVID-19.

What stocks does MarketBeat like better than Emisphere Technologies?

Wall Street analysts have given Emisphere Technologies a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Emisphere Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Emisphere Technologies' earnings last quarter?

Emisphere Technologies, Inc. (OTCMKTS:EMIS) announced its earnings results on Friday, May, 12th. The company reported $0.04 earnings per share (EPS) for the quarter. The business had revenue of $0.22 million for the quarter.
View Emisphere Technologies' earnings history.

Are investors shorting Emisphere Technologies?

Emisphere Technologies saw a decrease in short interest in November. As of November 15th, there was short interest totaling 4,200 shares, a decrease of 49.4% from the October 31st total of 8,300 shares. Based on an average daily volume of 281,100 shares, the days-to-cover ratio is currently 0.0 days.
View Emisphere Technologies' Short Interest.

Who are some of Emisphere Technologies' key competitors?

Some companies that are related to Emisphere Technologies include Pacira BioSciences (PCRX), Zymeworks (ZYME), Atea Pharmaceuticals (AVIR), Seres Therapeutics (MCRB), Xencor (XNCR), uniQure (QURE), Generation Bio (GBIO), Viela Bio (VIE), I-Mab (IMAB), Myovant Sciences (MYOV), Kura Oncology (KURA), Y-mAbs Therapeutics (YMAB), Zentalis Pharmaceuticals (ZNTL), Intra-Cellular Therapies (ITCI) and Amarin (AMRN).
View all competitors.

What other stocks do shareholders of Emisphere Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Emisphere Technologies investors own include Novo Nordisk A/S (NVO), Kintara Therapeutics (DMPI), Fulcrum Therapeutics (FULC), VIVUS (VVUS), Allena Pharmaceuticals (ALNA), Capricor Therapeutics (CAPR), Aldeyra Therapeutics (ALDX), CymaBay Therapeutics (CBAY), Cerecor (CERC) and Cumberland Pharmaceuticals (CPIX).

Who are Emisphere Technologies' key executives?

Emisphere Technologies' management team includes the following people:
  • Mr. Alan L. Rubino, Advisor (Age 65)
  • Mr. Alan V. Gallantar CPA, Interim Chief Financial Officer (Age 62)

What is Emisphere Technologies' stock symbol?

Emisphere Technologies trades on the OTCMKTS under the ticker symbol "EMIS."

How do I buy shares of Emisphere Technologies?

Shares of EMIS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Emisphere Technologies' stock price today?

One share of EMIS stock can currently be purchased for approximately $7.80.

How big of a company is Emisphere Technologies?

Emisphere Technologies has a market capitalization of $672.22 million. Emisphere Technologies employs 6 workers across the globe.

What is Emisphere Technologies' official website?

The official website for Emisphere Technologies is www.emisphere.com.

How can I contact Emisphere Technologies?

Emisphere Technologies' mailing address is 4 BECKER FARM ROAD SUITE 103, ROSELAND NJ, 07068. The company can be reached via phone at 973-532-8000 or via email at [email protected]

This page was last updated on 12/5/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.